KALVKalVista Pharmaceuticals, Inc.Mar 25, 2026Q1 2025
Read transcript →KalVista Pharmaceuticals, Inc. (KALV) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$27.00
—
Mkt Cap $1.44B
KALVKalVista Pharmaceuticals, Inc.Mar 25, 2026KALVKalVista Pharmaceuticals, Inc.Nov 11, 2025Q3 2025
Read transcript →KALVKalVista Pharmaceuticals, Inc.Sep 11, 2025Q1 2026
Read transcript →